Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
03/2003
03/20/2003US20030054384 Integrated systems and methods for diversity generation and screening
03/20/2003US20030054383 Apparatus for use in the generation of preferential nucleotide sequences
03/20/2003US20030054382 Infection of eukaryotic cells with viruses in vitro
03/20/2003US20030054381 Nucleotide sequences for use in forensics and heredity testing; for use in the diagnosis and treatment of respiratory and blood disorder
03/20/2003US20030054380 Diagnosing long qt syndrome; obtain sample, extract nucleotide sequences, incubate with probe, detect polymorphism, presence of polymorphism indicates long qt syndrome
03/20/2003US20030054376 Detection of preferential particle in sample using detechable linker; prepare bead complex, incubate with sample, allow associations to occur, cleave space, recover complexed beads
03/20/2003US20030054373 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of prostate cancer
03/20/2003US20030054372 Method for the determination of a nucleic acid using a control
03/20/2003US20030054368 Nucleic acids, proteins and antibodies
03/20/2003US20030054367 Method for correlating gene expression profiles with protein expression profiles
03/20/2003US20030054366 Compositions, kits, and methods for identification, assessment, prevention, and therapy of human colon cancer
03/20/2003US20030054361 Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system
03/20/2003US20030054359 Nucleotide sequences coding polypeptide for use in the treatment, diagnosis and prevention of cancer and nervous system disorders
03/20/2003US20030054357 Monitoring the proliferation of cultured prostate cancer cells; obtain cells, incubate with quercetin, monitor adjustment in gene expression, decrease in androgen receptor gene expression indicate cell proliferation inhibitor
03/20/2003US20030054356 Multiple reporter read-out for bioassays
03/20/2003US20030054352 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054351 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054350 TCF-1 nucleotide sequence variation
03/20/2003US20030054349 Secreted and transmembrane polypeptides and nucleic acids encoding the same
03/20/2003US20030054348 Methods of identifying the activity of gene products
03/20/2003US20030054346 Screening nucleotide sequence for hybridization activity; obtain nucleotide sequences, determine sequence, compare to hybrid pair, detect segment of chromosome with complimentary sequences
03/20/2003US20030054342 Measurements of multiple molecules using a cryoarray
03/20/2003US20030054341 Viral nucleotide sequences for use in diagnosis, prevention and treatment of viral diseases
03/20/2003US20030054340 Neural tracing with a conditional herpesvirus and methods and uses thereof
03/20/2003US20030054336 Diagnosing viral diseases; obtain fluid sample, incubate with immunoassay reaction mixture, detect signal, presence of signal indicate viral disease
03/20/2003US20030054334 Medical and diagnostic use of a specific co-activator for human nuclear receptors
03/20/2003US20030054333 Biosensor for use as diagnostic tool in monitoring cell metabolism
03/20/2003US20030054332 Monitor therapeutic activity of estrogen modulator; obtain vascular endothelial cell, incubate with modulator, monitor expression of estrogen marker, presence of estrogen marker indicates modulator of cardiovascular activity
03/20/2003US20030054054 Antitumor agent
03/20/2003US20030054053 Methods and compositions for inhibiting the proliferation of prostate cancer cells
03/20/2003US20030054008 Mycobacterial proteins, microorganisms producing them and their use for vaccines and for the detection of tuberculosis
03/20/2003US20030054006 Screen for cancer sensitivity using antibody
03/20/2003US20030054005 Using monoclonal antibodies; polymerase chain reactions
03/20/2003US20030054003 Antitumor agents, anticarcinogenic agents
03/20/2003US20030054000 Anti-pathogen system and methods of use thereof
03/20/2003US20030053993 Regeneration of nerve cells
03/20/2003US20030053991 Retinoic acid receptor beta-2, its agonists, and gene theraphy vectors for the treatment of neurological disorders
03/20/2003US20030053953 Wherein void comprises vapor of volatile liquid (aliphatic hydrocarbons, chlorofluorocarbons, tetraalkyl silanes, and perfluorocarbons); for computed tomography imaging of the gastrointestinal region
03/20/2003US20030053950 Metabolic phenotyping via administration of probe for HMG CoA reductase inhibitor (hydroxy-3-methylglutaryl/3-coenzyme A); comprises microgravimetric sensors
03/20/2003US20030053935 Includes semiconductive polymer film which swells when exposed to analyte and interferents; easily transportable
03/20/2003US20030053934 Wherenin microcavity between inlet conduit and restriction conduit in each microchannel structure creates flow with low inter-channel variation
03/20/2003US20030053515 Method for analyzing thermal deformation
03/20/2003US20030053065 Device and method for irradiation
03/20/2003US20030052692 Writing pen with a liquid crystal screen displaying the tested alcohol concentration value
03/20/2003US20030052005 Hydrogen sensor
03/20/2003US20030052002 Multiaperture sample positioning and analysis system
03/20/2003US20030051602 Gas carry-under monitoring and control system
03/20/2003US20030051565 Heated enclosure purge system
03/20/2003US20030051535 Characterization of fluids using ultrasound
03/20/2003DE20202129U1 Test kit for diagnosing neuroimmunological health disorders comprises at least one harmful substance at subtoxic concentration, a lymphocyte incubation device and a unit for detecting (pro)inflammatory and regulatory cytokines
03/20/2003CA2783186A1 Assay buffer, compositions containing the same, and methods of using the same
03/20/2003CA2764284A1 A system and method for providing closed loop infusion formulation delivery
03/20/2003CA2743332A1 Method and apparatus for assay based on light diffraction
03/20/2003CA2488684A1 Glucosyltransferases which glucosylate abscisic acid
03/20/2003CA2466896A1 Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
03/20/2003CA2462574A1 Subunit respiratory syncytial virus vaccine preparation
03/20/2003CA2461692A1 Use of a protein of the crmp family for treating diseases related to the immune system
03/20/2003CA2460509A1 Synthetic hcv envelope proteins and their use for vaccination
03/20/2003CA2460496A1 Methods of detection of conformational change in a nucleic acid duplex by treatment with oxidising or reactive agent as a result of exposure to environmental or chemical conditions
03/20/2003CA2460233A1 Method and apparatus for assay based on light diffraction
03/20/2003CA2460189A1 Diagnosis and monitoring of systemic lupus erythematosus and of scleroderma
03/20/2003CA2460117A1 Expression profiling in the intact human heart
03/20/2003CA2460092A1 A method of diagnosis and treatment and agents useful for same
03/20/2003CA2460049A1 Enhanced resolution of tumor metastasis
03/20/2003CA2459947A1 Compositions and methods for aa4rp assay
03/20/2003CA2459945A1 Methods of screening molecules that are used to prevent cardiovascular diseases
03/20/2003CA2459893A1 Methods and apparatus for conducting multiple measurements on a sample
03/20/2003CA2459890A1 Crystal structure of baff, and use thereof in drug design
03/20/2003CA2459729A1 Methods for producing ex vivo models for inflammatory disease and uses thereof
03/20/2003CA2459703A1 A luminescence-based sensor assembly
03/20/2003CA2459510A1 Food allergens, method of detecting food allergens and method of detecting food allergy-inducing foods
03/20/2003CA2459500A1 Diagnostic method for transmissible spongiform encephalopathies
03/20/2003CA2459462A1 Microcantilever apparatus and methods for detection of enzymes
03/20/2003CA2459373A1 Method of evaluating efficacy of nucleic acid therapy
03/20/2003CA2459318A1 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003CA2459310A1 Method and composition for treating immune complex associated disorders
03/20/2003CA2455990A1 Methods for diagnosing and treating diseases and conditions associated with protein kinase c.lambda.
03/20/2003CA2451454A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003CA2451254A1 Novel proteins and nucleic acids encoding same
03/19/2003WO2003016914A1 A kit for the simultaneous diagnosis of a plurality of infectious diseases and a method for preparation of it
03/19/2003EP1293926A2 Start control method in a computer system
03/19/2003EP1293780A2 Specific binding analysis method
03/19/2003EP1293779A2 Biosensor surface
03/19/2003EP1293778A2 Method and apparatus for concentration monitoring in fluids
03/19/2003EP1293777A2 Hydrogen sensor
03/19/2003EP1293776A2 Apparatus for measuring concentration of ammonia gas
03/19/2003EP1293775A2 Examination method of buffer capacity of saliva and examination instrument of buffer capacity of saliva
03/19/2003EP1293774A1 Method for calibrating gas analysers
03/19/2003EP1293769A2 Flammable gas sensor and gas concentration measurement method and apparatus
03/19/2003EP1293574A2 Reagents, methods and devices for detecting analytes
03/19/2003EP1293565A2 Mammalian telomerase RNA component
03/19/2003EP1293562A1 Fungal glyoxal oxidases
03/19/2003EP1293514A1 Multimeric single chain tandem Fv-antibodies
03/19/2003EP1293512A2 DNA encoding the baboon and cynomolgus macaque prostaglandin E2 receptor EP4 subtype
03/19/2003EP1293205A1 Valproic acid and derivatives thereof for the combination therapy of human cancers, for the treatment of tumour metastasis and minimal residual disease
03/19/2003EP1293201A2 Use of aminoadamantane compounds as immunoregulators
03/19/2003EP1293108A1 Waterless vessel heating system and method
03/19/2003EP1292830A2 Method for identifying insulin mimics or antagonists
03/19/2003EP1292829A1 No wash bead assay, kit and procedure
03/19/2003EP1292828A2 Particles and their use in molecular imprinting
1 ... 2631 2632 2633 2634 2635 2636 2637 2638 2639 2640 2641 2642 2643 2644 2645 2646 2647 2648 2649 2650 2651 ... 3937